Laurantis Pharma Oy
Pharmacity
Itäinen Pitkäkatu 4 B
FI-20520
Turku
Tel: 358-0-2-4788-378
Fax: 358-0-2-4788-371
Website: http://www.laurantis.com/
7 articles about Laurantis Pharma Oy
-
Laurantis Pharma Oy and Ark Therapeutics Sign Manufacturing Agreement for Production of Lymfactin Investigational Treatment for Breast Cancer-Associated Lymphedema
10/15/2012
-
Laurantis Pharma Oy Issued Patent for Cis-UCA as a Treatment for Bladder Cancer
10/9/2012
-
Laurantis Pharma Oy Completes Funding Round for Research Program
9/4/2012
-
U.S. Patent Office Allows Laurantis Pharma Oy Application for Treatment of Skin Inflammation
8/1/2012
-
Laurantis Pharma Oy Release: Investigational Cis-urocanic Acid Eye Drops for Dry Eye Syndrome Well Tolerated, in Phase 1 Clinical Study
6/28/2012
-
Laurantis Pharma Oy Release: Research Team Discovers Four-Fold Improvement in Ability to Restore Lymphatic Function With Adenovirally-Delivered VEGF-C Gene Therapy After Lymph Node Transplant Surgery Compared to the Surgery Alone
3/7/2012
-
Laurantis Pharma Oy Release: New Treatment for Lymphedema Could Mean Breakthrough for Breast Cancer Patients
9/22/2011